Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
67%(4 trials)

Phase Distribution

Ph phase_4
3
43%
Ph phase_2
2
29%
Ph phase_3
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
2(28.6%)
Phase 4Post-market surveillance
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(6)
Other(1)

Detailed Status

Completed6
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (28.6%)
Phase 32 (28.6%)
Phase 43 (42.9%)

Trials by Status

completed686%
suspended114%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_2

Practical Anemia Bundle for SusTained Blood Recovery

NCT05167734
completedphase_2

Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury

NCT05960227
completedphase_4

Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial

NCT03438227
completedphase_4

Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia

NCT05047211
completedphase_3

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia

NCT00704028
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05167734Phase 2

Practical Anemia Bundle for SusTained Blood Recovery

Completed
NCT05960227Phase 2

Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury

Completed
NCT03438227Phase 4

Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial

Completed
NCT05047211Phase 4

Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia

Completed
NCT00704028Phase 3

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia

Completed
NCT03212781Phase 3

Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women

Completed
NCT00593619Phase 4

Trial Comparing the Safety of Two Different Intravenous Iron Formulations

Suspended

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7